CVS congressional trades
CVS Health Corporation (CVS) appears in 18 congressional disclosure rows from 12 members of Congress in 2025–2026 periodic reports: 6 purchases and 12 sales, with trade dates from Aug 26, 2024 to Mar 27, 2026. Lisa McClain reported the most, with 3 rows. The median gap between trade date and filing date is 25 days, and 4 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live CVS portfolio or a trading signal.
- 18
- 12
- 6 / 12
- $46K to $340K
- sum of reported ranges
- 2026-03-27
Verified CVS congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 6 purchases and 12 sales. Reported owners: Self, Joint, Spouse. Transaction dates run from 2024-08-26 to 2026-03-27.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Alan Armstrong | CVS Health Corporation Common Stock | Purchase | Self | $1,001 - $15,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| John Boozman | CVS Corp | Purchase | Joint | $1,001 - $15,000 | #135ebfe9-099e-4d58-ba46-f739b90d61da Filed 2026-02-15 | |
| Dwight Evans | CVS Health Corporation Common Stock | Sale | Self | $1,001 - $15,000 | #20034556 Filed 2026-05-15 | |
| Dwight Evans | CVS Health Corporation Common Stock | Sale | Self | $1,001 - $15,000 | #20033667 Filed 2025-12-19 | |
| Lisa McClain | CVS Health Corporation Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | CVS Health Corporation Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | CVS Health Corporation Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Valerie Hoyle | CVS Health Corporation Common Stock | Sale | Spouse | $1,001 - $15,000 | #20032211 Filed 2025-10-10 | |
| Adam Smith | Spouse has chosen to divest of all the stocks contained within this IRA. As this is an Inherited Beneficiary IRA, there are no capital gains on this sale. CVS Health Corporation Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030868 Filed 2025-08-08 | |
| Robert Bresnahan | CVS Health Corporation Common Stock | Sale | Self | $1,001 - $15,000 | #20030433 Filed 2025-05-31 | |
| Jefferson Shreve | CVS Health Corporation Common Stock | Sale | Self | $15,001 - $50,000 | #20030387 Filed 2025-06-22 | |
| Julie Johnson | CVS Health Corporation Common Stock | Sale | Joint | $1,001 - $15,000 | #20030296 Filed 2025-05-14 | |
| Robert Bresnahan | CVS Health Corporation Common Stock | Purchase | Self | $1,001 - $15,000 | #20029034 Filed 2025-03-27 | |
| J. Hill | CVS Health Corporation Common Stock | Sale | Self | $15,001 - $50,000 | #20026706 Filed 2025-02-04 | |
| Gilbert Cisneros | CVS Health Corporation Common Stock | Purchase | Self | $1,001 - $15,000 | #20026726 Filed 2025-02-11 | |
| Julie Johnson | CVS Health Corporation Common Stock | Sale | Joint | $1,001 - $15,000 | #20026762 Filed 2025-02-12 | |
| Valerie Hoyle | CVS Health Corporation Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 | |
| Tommy Tuberville | CVS Health Corporation Common Stock | Sale | Joint | $1,001 - $15,000 | #2758f09a-fda9-4fb4-a465-270173a8125d Filed 2026-08-05 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
CVS disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Lisa McClain's CVS trades | 3 | 1 | 2 | 2025-10-31 |
| Dwight Evans | 2 | 0 | 2 | 2025-11-21 |
| Julie Johnson | 2 | 0 | 2 | 2025-04-01 |
| Robert Bresnahan | 2 | 1 | 1 | 2025-05-15 |
| Valerie Hoyle | 2 | 1 | 1 | 2025-09-23 |
| Adam Smith | 1 | 0 | 1 | 2025-08-08 |
| Alan Armstrong | 1 | 1 | 0 | 2026-03-27 |
| Gilbert Cisneros | 1 | 1 | 0 | 2025-01-24 |
| J. Hill | 1 | 0 | 1 | 2025-01-31 |
| Jefferson Shreve | 1 | 0 | 1 | 2025-05-12 |
| John Boozman | 1 | 1 | 0 | 2026-01-29 |
| Tommy Tuberville | 1 | 0 | 1 | 2024-08-26 |
How long disclosure took
Days from trade date to filing date for 18 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 2
- 16–30 days
- 10
- 31–45 days
- 2
- Over 45 days
- 4
- Median / longest
- 25d / 709d
Source documents
16 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #2758f09a-fda9-4fb4-a465-270173a8125dFiled 2026-08-05 · 1 row
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 1 row
- #20034556Filed 2026-05-15 · 1 row
- #135ebfe9-099e-4d58-ba46-f739b90d61daFiled 2026-02-15 · 1 row
- #20033667Filed 2025-12-19 · 1 row
- #20033446Filed 2025-11-21 · 3 rows
- #20032211Filed 2025-10-10 · 1 row
- #20032070Filed 2025-09-12 · 1 row
- #20030868Filed 2025-08-08 · 1 row
- #20030387Filed 2025-06-22 · 1 row
- #20030433Filed 2025-05-31 · 1 row
- #20030296Filed 2025-05-14 · 1 row
4 older filings are linked from the transaction table.
What CVS filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- CVS Health Corporation financials and filings
Audited SEC figures, what moves CVS, and primary sources.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
- Start here: how Yield Theory approaches research
Yield Theory is independent stock research for people investing their own money. Here is what's free, what members get, and three pieces to read first.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
CVS congressional trades: FAQ
Who in Congress traded CVS?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 18 verified CVS rows from 12 members: Adam Smith, Alan Armstrong, Dwight Evans, Gilbert Cisneros, and 8 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current CVS holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are CVS amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is CVS congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (178 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded CVS.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-11-04. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported CVS and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included